Lysostaphin freeze dried powder used for preventing and treating cattle edometritis
A technology of lysostaphin and freeze-dried powder, which is applied in the direction of anti-inflammatory agent, freeze-dried delivery, powder delivery, etc., can solve the problems of poor clinical effect, unfavorable breeding of dairy cows, endometrial fibrosis, etc., and achieve Promote the repair of uterine mucosa, strong bactericidal effect, strong bactericidal effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0036] The preparation of embodiment 1 lysostaphin freeze-dried powder
[0037] 1. Composition and ratio
[0038] Lysostaphin 0.4%; Bovine serum albumin 10%; Glycine 30%; Mannitol 10%; Potassium dihydrogen phosphate 15%; Disodium hydrogen phosphate 30%.
[0039] 2. Preparation of semi-finished products
[0040] Weigh solid KH 2 PO 4 and Na 2 HPO 4 .12H 2 O, prepare 0.2mol / L phosphate buffer A (pH value 6.5 phosphate buffer, concentration is 0.2M). According to the formulation prescription, weigh the required glycine and mannitol, measure the required volume of bovine serum albumin, add it to the part A solution, stir and dissolve, and obtain the solution B. Measure the stock solution of recombinant lysostaphin, add it to solution B, make the biological activity of recombinant lysostaphin in the final solution be 400U / ml, add A solution to the final volume, and what is obtained at this time is the recombinant lysostaphin Semi-finished solution.
[0041]...
Embodiment 2
[0047] Example 2 Rabbit Subcutaneous Injection Topical Recombinant Lysostaphin Repeated Administration Toxicity Test
[0048] 1. Purpose of the experiment
[0049] The purpose of this experiment is to observe the nature, degree, development and recovery of toxic reactions in rabbits through subcutaneous injection of recombinant lysostaphin for external use, so as to provide reference materials for clinical safety drug dosage design and clinical toxicity monitoring.
[0050] 2. Experimental method
[0051] 24 New Zealand white rabbits, weighing 2.5-3.0kg. There are 3 dosage groups for recombinant lysostaphin for external use, and the dosages are 100, 20 and 4mg.kg respectively. -1 (equivalent to 241936, 48387 and 9677U·m -2 ), the solvent control group (0.9% sodium chloride injection), the subcutaneous injection amount is 1mg.kg -1 . Administered continuously 7 days a week for a total of 4 weeks.
[0052] 3. Experimental results
[0053] After administration, the...
Embodiment 3
[0056] Embodiment 3 Lysostaphin freeze-dried powder stability test
[0057] 1. Test equipment
[0058] Test strain: Staphylococcus aureus (ATCC6538);
[0059] Neutralizer: 0.5% sodium thiosulfate, 2% Tween-80, 0.5% lecithin in PBS;
[0060] Phosphate buffer solution (PBS0.03mol / l pH7.2).
[0061] 2. Test method
[0062] The 24h slant culture of the test bacteria was washed with PBS to make a bacterial suspension.
[0063] Take 4 pieces each of the sample piece (2.0cm×3.0cm) and the control piece (the same material as the sample, the same size, but without antibacterial material, and sterilized), divide them into 4 groups and place them in 4 sterilized in the bacterial plate.
[0064] Take the above-mentioned bacterial suspension, add 100 μL dropwise on each test piece and control sample, spread evenly, start timing, and act for 2, 5, 10, 20 minutes, use sterile tweezers to drop the sample into the corresponding medium containing 5mL respectively. In the t...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com